WeVote
Log In

Bill

Bill

LB 1217

Authorize schools to maintain epinephrine for emergency first aid

109th Legislature (2025-2026) Introduced by John Cavanaugh and 1 co-sponsor

LB 1217 permits Nebraska schools to stock and administer epinephrine auto-injectors for emergency anaphylaxis treatment during student medical crises.

Notice of hearing for February 19, 2026
0
WeVote Research Nonpartisan
Bill Summary · LB 1217

Legislative bill overview

LB 1217 authorizes Nebraska schools to maintain and use epinephrine auto-injectors (EpiPens) on-site for emergency first aid treatment of anaphylactic reactions. The bill enables schools to stock these potentially life-saving devices and train designated staff members to administer them during medical emergencies.

Why is this important

Anaphylactic reactions can occur suddenly in school settings and require immediate treatment—delays of even minutes can be fatal. By allowing schools to keep epinephrine readily available, the bill addresses a critical gap in emergency response capacity, particularly for students with unknown or newly diagnosed allergies and situations where parental-provided auto-injectors are unavailable.

Potential points of contention

  • Liability concerns: Schools may resist participation due to fears about legal liability if epinephrine is administered inappropriately or causes adverse effects, even when used appropriately
  • Cost and resource burden: Schools must fund the purchase of epinephrine supplies, staff training, and maintenance of expiring medications, raising equity questions about resource-strapped districts
  • Medical oversight gaps: Questions about which staff can administer the drug, liability protections for those administering it, and whether medical protocols are sufficiently detailed in the legislation

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.